Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis

Vincenzo De Luca1, Daniel J Mueller, Andrea de Bartolomeis

  • 1University of Toronto, Centre for Addiction and Mental Health, Neurogenetics Section, Toronto, ON, Canada. vincenzo_deluca@CAMH.net

Insights

The serotonin 5-HT2C receptor gene (HTR2C) shows a slight association with weight gain. Larger sample sizes are needed to confirm the role of HTR2C pharmacogenetics in clinical psychiatry.

Area of Science:

  • Neuroscience
  • Pharmacogenetics
  • Genetics

Background:

  • The serotonin 5-HT2C receptor (HTR2C) is implicated in regulating feeding behavior.
  • HTR2C gene knockout mice exhibit obesity, and some antipsychotics targeting this receptor can cause weight gain.

Purpose of the Study:

  • To investigate the association between the HTR2C gene and weight gain.
  • To analyze the -759C/T promoter polymorphism (rs3813929) using meta-analytical techniques.

Main Methods:

  • Meta-analysis of published studies on the HTR2C -759C/T polymorphism and weight gain.
  • Investigation of potential moderation by ancestry (Caucasian vs. Asian) and clinical factors.

Main Results:

  • A slight association was found between the HTR2C -759C/T polymorphism and weight gain.
  • Significant heterogeneity was observed between studies, suggesting moderating factors.

Conclusions:

  • The meta-analysis supports a role for HTR2C in weight gain.
  • Larger sample sizes are crucial for definitively establishing the clinical psychiatric relevance of HTR2C pharmacogenetics.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...